Shingles vaccine study for healthy adults 50-65
Treatments studied
Part of Infections clinical trials.
This trial tests a new shingles vaccine in healthy adults aged 50 to 65. Shingles can cause a painful rash, and the vaccine aims to prevent it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 65 years old
- You have never had shingles before
- You do not have a weakened immune system or take medications that suppress your immune system
- You have not received a shingles or chickenpox vaccine before
- You are not pregnant or breastfeeding, and agree to use birth control if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine to see if it's safe and helps the body build immunity. It is for healthy adults aged 50 and older who have not had shingles before.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This trial tests a new mRNA vaccine (IN001) to prevent shingles. It is for healthy adults aged 50 to 79 who have never had shingles or been vaccinated against it.
This study tests a new shingles vaccine for people 40 and older. It looks at safety, how well the body responds, and whether it can prevent shingles.
This study tests an experimental shingles vaccine in adults aged 40 and older. It aims to see if the vaccine is safe and helps your body build immunity against shingles.
This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.
Hear when a new Vaccine-Preventable Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.